Flyover Capital
VC Fund
Overland Park, United States
Flyover Capital is a venture capital firm that invests in early-stage companies funds. We do one thing, and we do it well: We support people who are underestimated for no reason other than doing business in the Flyover region. When we invest, we do it early — and with great conviction. Then we get to work because your success is our success.We're here for you in the good times and especially the bad times, all to ensure you have the resources to be successful.
- Total investments:
- 68
- Last investment:
- Lead investor:
- 49%
- Fund size:
- $60M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Flyover Capital invests in
Stages Flyover Capital invests in
Countries Flyover Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Software 12 (18%)
- Artificial Intelligence 10 (15%)
- SaaS 8 (12%)
- Information Technology 8 (12%)
- Information Services 7 (10%)
Stage
- Seed 23 (34%)
- Series A 18 (26%)
- Funding Round 7 (10%)
- Pre-Seed 5 (7%)
- Series B 4 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Dan Kerr
Partner
|
Partner | Total investments: 3 | Find email | |
Katie Coens
Analyst
|
Analyst | Total investments: 0 | Find email | |
Keith Molzer
Co-Founder & Managing Partner
|
Co-Founder & Managing Partner | Total investments: 16 | Find email | |
Patrick Berry
Senior Associate
|
Senior Associate | Total investments: 2 | Find email | |
Thad Langford
Co-Founder & Managing Partner
|
Co-Founder & Managing Partner | Total investments: 12 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Quercus Biosolutions
|
Quercus aims to create effective, environmentally friendly alternatives to chemical pesticides by designing proteins from scratch, which can be regulated as biopesticides. This approach promises faster development and deployment compared to traditional methods, with potential for significant advancements in crop protection over the next few years. | $5M / Seed / Jul 29, 2026 | |
Paralign Health
|
Paralign Health is a primary healthcare organization that delivers in-home preventive care and community paramedicine. It partners with fire departments and EMS to provide health assessments, monitor chronic conditions, and coordinate care for patients in underserved areas. | $3M / Seed / May 20, 2026 | |
Trially
|
Trially brings deep knowledge of the clinical trial landscape together with cutting-edge AI, offering unprecedented agility to research. | $4.7M / Seed / Sep 16, 2025 | |
Dispatch
|
Dispatch helps independent financial advisors to build ideal firms through strategic investments and advanced technology. | $18M / Series A / Sep 04, 2025 | |
dScribe AI
|
dScribe AI serves the function of analyzing any video online using only its link. dScribe AI takes care of the demanding work of managing audio and video content for social media, so you can concentrate on what matters for your business. dScribe AI has you covered, whether you're a developer wanting to incorporate social media analysis intoyour app, a business aiming to gain a better understanding of your audience, or an enterprise in need of mass brand protection. | $1.7M / Pre-Seed / Mar 05, 2025 | |
Mavvrik
|
DigitalEx is an AI-driven hybrid cloud cost management solutions startup that specialises in delivering unique solutions that allow businesses to monitor, analyze, and optimise their cloud expenses and usage. | Seed / Feb 19, 2025 | |
Mavvrik
|
Mavvrik is the financial control center for modern IT, providing enterprises with complete visibility, automation, and governance across cloud, AI, SaaS, and on-prem infrastructure. Built for CFOs, FinOps, and IT leaders, Mavvrik eliminates financial blind spots, enforces accountability, and transforms IT costs into strategic investments. Withreal-time cost tracking, automated chargebacks, and predictive budget controls, Mavvrik helps enterprises reduce waste, optimize AI and hybrid cloud spend, and maintain financial precision at scale. | $6.2M / Seed / Feb 19, 2025 | |
Aetos Imaging
|
Aetos leverages advanced 3D technology to give facility personnel the information they need to do the job. Our visual management platform captures and presents the institutional knowledge of your operations. Unlock the power of implementing virtual equipment databases, customized site-specific training, and remote collaboration. Consolidate andstreamline all of your operations into one visual platform with Aetos. | $4M / Seed / Feb 11, 2025 | |
Invary
|
Invary is an Enterprise-grade cybersecurity platform focused on operating system runtime validation and security, detecting hidden malware and preventing costly ransomware attacks. | $3.5M / Seed / Feb 03, 2025 | |
ChampionHQ
|
ChampionHQ operates as a customer marketing platform to activate your customers and fans to create post-sale marketing programs. | $3.3M / Seed / Sep 03, 2024 | |
| See all 68 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Flyover Capital invest in?
Flyover Capital invests primarily in Software, Artificial Intelligence and SaaS startups, most often at Seed and Series A stage. Most of the 68 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Flyover Capital?
Public channels for Flyover Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Flyover Capital?
The team at Flyover Capital includes Dan Kerr (Partner), Katie Coens (Analyst) and Keith Molzer (Co-Founder & Managing Partner), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
